Guidelines for Contrast Administration — MCQs
I/V contrast is not used in -
Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?
Which contrast agent is not used for CT scans?
Contrast material used in the diagnosis of esophageal atresia is:
To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?
GFR for assessment of impaired renal function is best measured by
In a child, non-functioning kidney is best diagnosed by
All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?
Which of the following conditions is associated with contrast nephropathy?
Which of the following investigations must be performed before administering contrast to a patient?
Guidelines for Contrast Administration Indian Medical PG Practice Questions and MCQs
Question 1: I/V contrast is not used in -
- A. IVP
- B. Myelography (Correct Answer)
- C. MRI
- D. CT scan
Explanation: ***Myelography*** - Myelography involves injecting contrast material directly into the **subarachnoid space** of the spinal canal to visualize nerve roots and the spinal cord, and therefore does not use intravenous contrast. - The contrast in myelography is typically **iodinated non-ionic contrast** injected intrathecally, not intravenously. *IVP* - **Intravenous Pyelogram (IVP)** is a radiological procedure that specifically uses **intravenous iodinated contrast** to visualize the kidneys, ureters, and bladder. - The contrast is excreted by the kidneys, highlighting the urinary tract structures on X-ray images. *MRI* - While many MRI scans do not require contrast, **intravenous gadolinium-based contrast agents** are commonly used to enhance visualization of certain pathologies like tumors, inflammation, or vascular anomalies. - The contrast is administered intravenously to accumulate in areas with increased vascularity or disrupted blood-brain barrier. *CT scan* - **CT scans** frequently utilize **intravenous iodinated contrast** to improve the visibility of blood vessels, organs, and various lesions like tumors or inflammatory processes. - The contrast enhances density differences between tissues, making pathologies more conspicuous.
Question 2: Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?
- A. Iso-osmolar contrast (Correct Answer)
- B. High osmolar contrast
- C. Ionic contrast
- D. Low osmolar contrast
Explanation: ***Iso-osmolar contrast*** - **Iso-osmolar contrast agents** (e.g., iodixanol) have an osmolality of ~290 mOsm/kg, which is identical to that of plasma. - **This is the PREFERRED choice** in patients with renal dysfunction as multiple studies demonstrate the lowest risk of contrast-induced nephropathy (CIN). - The iso-osmolar formulation minimizes osmotic stress on renal tubules and reduces the risk of acute kidney injury. - **Current guidelines recommend iso-osmolar agents as first-line** in high-risk patients with pre-existing renal impairment. *Low osmolar contrast* - **Low osmolar contrast agents** have osmolality of 600-900 mOsm/kg, which is significantly lower than high osmolar agents but still 2-3 times higher than plasma. - While **acceptable and safer than high osmolar agents**, they are not as optimal as iso-osmolar contrast for patients with renal dysfunction. - These agents are widely used and represent a reasonable alternative when iso-osmolar agents are not available. *High osmolar contrast* - **High osmolar contrast agents** have osmolality >1400 mOsm/kg (about 5 times that of plasma). - They carry the **highest risk of contrast-induced nephropathy** due to severe osmotic load and direct tubular toxicity. - **Contraindicated or strongly avoided** in patients with pre-existing renal dysfunction. *Ionic contrast* - **Ionic contrast** refers to the chemical structure (dissociates into ions) rather than osmolality. - Can be either high or low osmolar—the ionic nature alone does not determine renal safety. - The critical factor for nephrotoxicity prevention is osmolality, not ionic charge.
Question 3: Which contrast agent is not used for CT scans?
- A. CO2 (Correct Answer)
- B. Iodinated high-osmolality contrast media
- C. Barium compounds
- D. Gadolinium-based contrast agents
Explanation: ***CO2*** - **CO2** (carbon dioxide) is **not used as a contrast agent in CT scans**. - CO2 is primarily used in **angiography** (especially for peripheral vessels in patients with iodine allergy or renal insufficiency) where it acts as a negative contrast agent. - In CT, CO2 would appear as air/gas density and create artifacts rather than providing diagnostic enhancement, making it unsuitable for routine CT imaging. *Iodinated high-osmolality contrast media* - These are **iodinated contrast agents** that contain iodine atoms which strongly attenuate X-rays, making them highly effective for **CT imaging**. - High-osmolality contrast media (HOCM) like **diatrizoate** and **iothalamate** were the standard CT contrast agents historically. - They have largely been replaced by **low-osmolality** and **iso-osmolality** agents due to higher incidence of **adverse reactions**, but they are still used for CT scans. *Barium compounds* - **Barium sulfate** suspensions are widely used as **oral or rectal contrast agents** for CT imaging of the gastrointestinal tract. - Barium has high atomic number and effectively attenuates X-rays, making the **GI lumen clearly visible** on CT scans. - Used in **CT enterography**, **CT colonography**, and routine **abdominal/pelvic CT** protocols. *Gadolinium-based contrast agents* - **Gadolinium-based contrast agents (GBCAs)** are primarily designed for **MRI** due to their **paramagnetic properties**. - However, gadolinium DOES attenuate X-rays and can be used **off-label for CT** in patients with **severe iodine allergy** or **contraindications to iodinated contrast**. - While less effective than iodinated agents for CT (requiring higher doses), gadolinium-enhanced CT is a recognized alternative in special clinical circumstances.
Question 4: Contrast material used in the diagnosis of esophageal atresia is:
- A. Conray
- B. Gastrograffin (Correct Answer)
- C. Barium swallow
- D. Iohexol (Omnipaque)
Explanation: ***Gastrograffin*** - **Gastrograffin** (diatrizoate meglumine) is the **traditional standard** water-soluble iodinated contrast agent for diagnosing **esophageal atresia**. - Historically preferred because if aspirated, it is absorbed from the lungs, unlike barium which causes severe pneumonitis. - **Note**: Modern practice increasingly favors **non-ionic, low-osmolar agents** (like Iohexol) due to Gastrograffin's hyperosmolarity, but **Gastrograffin remains the textbook answer** for most competitive exams. *Conray* - **Conray** (iothalamate meglumine) is an ionic iodinated contrast agent, primarily used for angiography and excretory urography. - Not typically recommended for esophageal studies in neonates with suspected **atresia**, due to its higher osmolality and potential complications if aspirated. *Barium swallow* - **Barium sulfate** is **absolutely contraindicated** in cases of suspected **esophageal atresia** or perforation. - If aspirated into the lungs, **barium** causes severe **chemical pneumonitis**, granuloma formation, and potentially **ARDS**, with significant morbidity and mortality. - Barium is not absorbed and remains in lung tissue, causing chronic inflammation. *Iohexol (Omnipaque)* - **Iohexol (Omnipaque)** is a **non-ionic, low-osmolar contrast agent** that is actually **safer than Gastrograffin** if aspirated. - In modern practice, non-ionic agents like Iohexol are increasingly preferred for esophageal studies due to lower osmolality and reduced risk of pulmonary edema. - However, for **exam purposes**, **Gastrograffin** remains the standard answer based on traditional teaching and most Indian textbooks.
Question 5: To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?
- A. Increase MAS
- B. Decrease KVP
- C. Increase KVP (Correct Answer)
- D. Decrease MAS
Explanation: ***Increase KVP*** - Increasing the **kilovoltage peak (KVP)** is essential for imaging morbidly obese patients because it increases the **penetrating power** of the X-ray beam, allowing adequate transmission through thick body tissues. - Higher KVP (typically 90-120 kVp range) ensures the X-ray beam can penetrate increased soft tissue thickness and reach the image receptor with sufficient intensity. - While higher KVP produces **longer scale (lower) contrast**, it is necessary for adequate **penetration** in obese patients - without sufficient KVP, the image would be underexposed and non-diagnostic. - In practice, both KVP and MAS are increased for obese patients, but **KVP increase is more critical** for penetration. *Increase MAS* - Increasing **milliampere-seconds (MAS)** increases the quantity of X-ray photons and image density (brightness), which is also helpful for obese patients. - However, MAS alone without adequate KVP cannot solve the penetration problem - the photons would still be too low energy to penetrate thick tissues effectively. - MAS increase without KVP increase would result in high patient dose with poor image quality. *Decrease KVP* - Decreasing KVP reduces **beam penetration**, which would be catastrophic for imaging an obese patient. - The X-ray beam would be absorbed by superficial tissues, resulting in a severely **underexposed** and non-diagnostic image. - While lower KVP produces higher contrast in theory, it is completely inappropriate for thick body parts. *Decrease MAS* - Decreasing MAS reduces the number of X-ray photons, resulting in an **underexposed, lighter** image. - This would make it even more difficult to obtain adequate imaging through increased body mass, resulting in a non-diagnostic radiograph with excessive quantum mottle.
Question 6: GFR for assessment of impaired renal function is best measured by
- A. MAG3
- B. IodoHippurate
- C. DTPA (Correct Answer)
- D. DMSA Scan
Explanation: ***DTPA*** - **Diethylene Triamine Pentaacetic Acid (DTPA)** is the primary radiopharmaceutical used to measure **glomerular filtration rate (GFR)**, which is the gold standard for quantifying renal function. - DTPA is freely filtered by the glomeruli and not reabsorbed or secreted by the tubules, making it an excellent tracer for evaluating glomerular function and assessing the degree of renal impairment. - **Note:** While MAG3 is often preferred for dynamic renal imaging in patients with severe renal impairment (GFR < 30 ml/min) due to better image quality, DTPA remains the standard for direct GFR measurement. *MAG3* - **Mercaptoacetyltriglycine (MAG3)** is used to assess **effective renal plasma flow (ERPF)** and tubular secretion, not GFR. - MAG3 is actually preferred over DTPA for dynamic renal scintigraphy in patients with poor renal function because of its superior extraction efficiency and image quality. - However, it does not directly measure GFR, which is the primary parameter for quantifying impaired renal function. *IodoHippurate* - **IodoHippurate** (I-123 or I-131 labeled) is used to measure **effective renal plasma flow (ERPF)** through tubular secretion. - While it provides information about renal blood flow, it does not directly measure GFR and is not the primary agent for assessing the degree of renal functional impairment. *DMSA Scan* - **Dimercaptosuccinic acid (DMSA)** is used for **static cortical imaging** to assess renal parenchymal structure and detect abnormalities like renal scarring, differential renal function, or pyelonephritis. - DMSA binds to the proximal tubular cells and provides anatomical information, but does not assess dynamic renal function or measure GFR.
Question 7: In a child, non-functioning kidney is best diagnosed by
- A. Creatinine clearance
- B. Ultrasonography
- C. IVU
- D. DTPA renogram (Correct Answer)
Explanation: ***DTPA renogram*** - A **DTPA renogram** (diethylene triamine pentaacetic acid scan) is a nuclear medicine study that assesses **renal blood flow** and **glomerular filtration rate (GFR)**. - It is highly effective in determining if a kidney is non-functioning because it directly measures the **uptake and excretion of a radiotracer** by the kidney, providing quantitative data on its functional capacity. *Creatinine clearance* - **Creatinine clearance** is a measure of overall kidney function, reflecting the GFR of **both kidneys combined**. - It cannot specifically identify a non-functioning individual kidney, as the other kidney might compensate for the non-functioning one, leading to a near-normal overall creatinine clearance. *Ultrasonography* - **Ultrasonography** is excellent for evaluating **renal anatomy**, such as size, shape, and presence of cysts, hydronephrosis, or stones. - While it can show structural abnormalities, it provides limited direct information about the **functional status** of the kidney, and a structurally normal kidney can still be non-functional. *IVU (Intravenous Urography)* - **Intravenous Urography (IVU)** uses contrast dye injected intravenously to visualize the kidneys, ureters, and bladder, assessing both anatomy and some aspects of function. - If a kidney is non-functioning, it would show **no uptake or excretion of the contrast dye**, but IVU involves radiation exposure and nephrotoxic contrast, making DTPA renogram often preferred in children for functional assessment.
Question 8: All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?
- A. N-acetyl cysteine
- B. Mannitol (Correct Answer)
- C. Fenoldopam
- D. Low osmolar contrast media (LOCM)
Explanation: **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with reduced GFR. The goal of management is to minimize renal vasoconstriction and oxidative stress. **Why Mannitol is the Correct Answer:** Historically, diuretics like **Mannitol** and Furosemide were thought to "flush" the kidneys. However, clinical trials (such as the PRINCE study) have shown that Mannitol is **ineffective** and may actually be **harmful**. It can cause osmotic diuresis leading to dehydration and further renal vasoconstriction, potentially worsening the risk of CIN. Therefore, it is no longer recommended. **Analysis of Other Options:** * **N-acetyl cysteine (NAC):** An antioxidant that scavenges free radicals and induces vasodilation. While its efficacy is debated in recent large trials (PRESERVE), it is still traditionally used in protocols to prevent CIN due to its low cost and safety profile. * **Fenoldopam:** A selective dopamine D1 receptor agonist that causes renal vasodilation. Though not routinely used due to cost and mixed evidence, it is pharmacologically intended to increase renal blood flow. * **Low Osmolar Contrast Media (LOCM):** High osmolar contrast (HOCM) is highly nephrotoxic. Switching to LOCM (e.g., Iohexol) or Iso-osmolar contrast (e.g., Iodixanol) significantly reduces the risk of CIN in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most effective preventive measure:** Adequate **Pre-procedure Hydration** with 0.9% Normal Saline is the gold standard. * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Metformin:** Must be withheld for 48 hours *after* the procedure to avoid lactic acidosis if renal failure occurs.
Question 9: Which of the following conditions is associated with contrast nephropathy?
- A. Diabetes nephropathy (Correct Answer)
- B. Hypertension
- C. Malignant hypertension
- D. Hypertensive glomerulosclerosis
Explanation: **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function (an increase in serum creatinine by >25% or >0.5 mg/dL) occurring within 48–72 hours of intravascular contrast administration. **Why Diabetes Nephropathy is the Correct Answer:** Diabetes mellitus, particularly when associated with pre-existing renal insufficiency (**Diabetic Nephropathy**), is the **single most significant independent risk factor** for developing CIN. The pathophysiology involves contrast-induced renal vasoconstriction leading to medullary ischemia and direct tubular cytotoxicity. In diabetic patients, the baseline oxidative stress and impaired vasodilatory capacity of the renal vasculature significantly potentiate these effects. **Analysis of Incorrect Options:** * **B, C, and D (Hypertension, Malignant Hypertension, Hypertensive Glomerulosclerosis):** While chronic hypertension can lead to renal damage, it is generally considered a secondary risk factor. Hypertension only significantly increases the risk of CIN if it has already progressed to significant **chronic kidney disease (CKD)** with a reduced Glomerular Filtration Rate (GFR). Diabetic nephropathy carries a much higher relative risk compared to hypertensive nephrosclerosis alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most Important Risk Factor:** Pre-existing renal insufficiency (low GFR). * **Most Effective Prophylaxis:** Intravenous hydration with **Isotonic Saline (0.9% NaCl)** or Sodium Bicarbonate before and after the procedure. * **Metformin Warning:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after contrast administration. * **Contrast Choice:** Non-ionic, **iso-osmolar** contrast media (e.g., Iodixanol) carry the lowest risk for nephropathy.
Question 10: Which of the following investigations must be performed before administering contrast to a patient?
- A. Kidney function test (KFT) (Correct Answer)
- B. Liver function test (LFT)
- C. Urine specific gravity
- D. Serum electrolytes
Explanation: **Explanation:** The administration of iodinated contrast media (used in CT scans and angiography) poses a significant risk of **Contrast-Induced Nephropathy (CIN)**. CIN is defined as an acute decline in renal function (increase in serum creatinine by >0.5 mg/dL or >25% from baseline) within 48–72 hours of contrast exposure. Therefore, assessing the **Kidney Function Test (KFT)**—specifically **Serum Creatinine** and the **estimated Glomerular Filtration Rate (eGFR)**—is mandatory to screen for pre-existing renal impairment, which is the strongest risk factor for CIN. **Analysis of Incorrect Options:** * **Liver Function Test (LFT):** While some contrast agents are excreted via the biliary system, hepatic impairment does not significantly increase the risk of acute toxicity or contrast reactions. * **Urine Specific Gravity:** This measures urine concentration and hydration status but is an unreliable indicator of the kidney's ability to clear contrast media compared to eGFR. * **Serum Electrolytes:** While important for general patient management, electrolyte imbalances are not a direct contraindication to contrast nor a primary predictor of contrast-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Threshold:** Contrast is generally considered safe if **eGFR >60 mL/min/1.73m²**. Caution is required if eGFR is between 30–60, and it is generally avoided (unless emergency) if **eGFR <30**. * **Prevention:** The most effective preventive measure for CIN is **intravenous hydration** with 0.9% Normal Saline before and after the procedure. * **Metformin:** In patients with renal impairment, Metformin should be withheld for 48 hours after contrast administration to prevent **Lactic Acidosis**. * **MRI Contrast:** For Gadolinium-based agents, the concern is **Nephrogenic Systemic Fibrosis (NSF)** in patients with severe renal failure.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free